Catalent Pharma Solutions

Will Downie has been appointed group president, Sterile Technologies and senior vice president of Global Sales and Marketing, Catalent Pharma Solutions, effective October 12, 2009. Mr. Downie will have full accountability for the Sterile Technologies segment, which includes the company’s injectable manufacturing businesses in Brussels, Belgium and Limoges, France, as well as its blow-fill-seal business, based in Woodstock, IL. Additionally, Mr. Downie will lead the global sales and marketing functions, including Catalent’s Global Account Sales team. He will report to John Chiminski, president and chief executive officer of Catalent, and will be based in Catalent’s Swindon, UK office.

Mr. Downie most recently served as vice president and global leader of GE Healthcare’s Molecular Imaging business, where he was responsible for leading a global organization of 1,800 people at five manufacturing sites. Prior positions at GE include vice president and general manager of medical diagnostics, Europe, Middle East and Africa; vice president and general manager, Europe; and vice president of sales for medical diagnostics, Europe. Prior to GE, Mr. Downie held senior management positions in operations, sales and marketing at Innovex UK Ltd., and commercial leadership positions with Sanofi-Synthelabo UK, Sanofi-Winthrop Ltd., and Merck.

Mr. Chiminski said, “I am pleased to welcome Will to the Catalent executive team.I’ve worked with him for a number of years, and I believe Will’s unique combination of business management experience and sales and marketing expertise will help us accelerate organic growth for both our Sterile business and the Company overall.”